FIELD: biotechnology.
SUBSTANCE: invention relates to an inhibitor of ATP-dependent reverse cell transporters belonging to a group of chiral conjugates (optically active hybrid molecules) of an oligoether polyol nature, as well as to a method for its production. The inhibitor is a mixture of polyoxypropylenehexole of formula 4
,
where n=2-6, and polyoxypropylene glycol of formula 5
,
where m=5-9, and has a hydroxyl number of 215-240 mg KOH/g. Compound 4 has a molecular weight of 1000 to 1500 Da, compound 5 has a molecular weight of 300 to 500 Da, and the mole ratio of compounds 4 and 5 is 0.9-1.1. The method for inhibitor production is to prepare a mixture of sorbitol ((2S, 3R, 4R, 5R)-hexane-1,2,3,4,5,6-hexol) and bifunctional oxygenate compound H-R-H, where R=-O-; [-OCH2CH (CH3)]k-O-, and k=1-7, in the presence of an alkali or alkaline earth metal hydroxide, with further interaction of this mixture with propylene oxide, neutralisation of the product obtained with acid and subsequent purification of the product.
EFFECT: increased yield.
3 cl, 9 dwg, 4 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR COMPOSITION OF DOXORUBICIN WITH ATP INHIBITOR-DEPENDENT REVERSE CELL TRANSPORTER | 2018 |
|
RU2680834C1 |
TRIFUNCTIONAL ETHYLENE OXIDE AND PROPYLENE OXIDE BLOCK COPOLYMERS FOR ACTIVE SUBSTANCE DELIVERY TO LIVING CELLS | 2012 |
|
RU2501570C1 |
METHOD AND COMPOSITION FOR TREATING CANCER | 2011 |
|
RU2541100C2 |
RAPAMYCIN TARGET INHIBITOR IN MAMMALIAN CELLS, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2019 |
|
RU2768583C2 |
ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
CONJUGATE OF ANTITUMOUR DRUGS WITH RECOMBINANT ALPHA-FETOPROTEIN AND ITS FUNCTIONAL FRAGMENTS AND METHOD OF THEIR PRODUCING | 2016 |
|
RU2630974C1 |
ANTICANCER POLYMER AGENTS | 2007 |
|
RU2432168C2 |
POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
CONSORTIUM OF PROBIOTIC STRAINS OF Lactobacillus rhamnosus AND Lactobacillus plantarum FOR PRODUCING BACTERIAL PREPARATION AND DIRECT ADMINISTRATION FERMENT FOR PRODUCING FERMENTED MILK AND FERMENTED BEET JUICE | 2012 |
|
RU2506308C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS | 2019 |
|
RU2710273C1 |
Authors
Dates
2018-01-17—Published
2016-11-02—Filed